MINI REVIEW article

Front. Cell Dev. Biol.

Sec. Molecular and Cellular Reproduction

Volume 13 - 2025 | doi: 10.3389/fcell.2025.1619758

This article is part of the Research TopicThe Fertilization Success from the Oocyte's Perspective, Volume IIView all 4 articles

Oocyte and Dietary Supplements: A Mini Review

Provisionally accepted
Hao  ChenHao Chen1Shuoqi  WangShuoqi Wang1Meiying  SongMeiying Song1Dongxia  YangDongxia Yang2Hongmei  LiHongmei Li2*
  • 1Heilongjiang University of chinese medicine, Harbin, China
  • 2Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China

The final, formatted version of the article will be published soon.

Rising rates of infertility have stimulated interest in dietary supplements to improve oocyte quality through mitochondrial function, antioxidant activity, and epigenetically regulated metabolic pathways. Mitochondria provides adenosine triphosphate for oocyte maturation, with Coenzyme Q10 (CoQ10) demonstrating efficacy in animal models by alleviating oxidative damage and enhancing blastocyst formation. In aged mice, CoQ10 restored mitochondrial activity and reduced chromosomal abnormalities, while preliminary human studies noted improved embryo quality in poor responders, though randomized controlled trials (RCTs) remain inconclusive. Antioxidants like melatonin counter reactive oxygen species (ROS)induced spindle defects and mitochondrial dysfunction, showing benefits in murine oocyte maturation and blastocyst development. Resveratrol enhanced bovine oocyte quality through metabolic modulation. Human trials on antioxidants show reduced granulosa cell stress but lack robust evidence. Epigenetically, folate supports DNA methylation critical for embryonic gene expression, with deficiencies linked to hyperhomocysteinemia and developmental defects in animal models. Human observational studies associate folate-rich diets with lower aneuploidy and better assisted reproductive technology outcomes, while omega-3 fatty acids aid chromatin remodeling via histone deacetylase regulation. Despite compelling preclinical data, human trials face inconsistencies due to variable designs and confounders. Standardized RCTs are urgently needed to translate mechanistic insights into clinical guidelines, addressing the disconnect between animal studies and human reproductive outcomes.

Keywords: Oocyte process, quality ovary, Dietary Supplements, Lifestyle Changes, clinical trials

Received: 28 Apr 2025; Accepted: 13 Jun 2025.

Copyright: © 2025 Chen, Wang, Song, Yang and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Hongmei Li, Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.